Mythic Therapeutics’ innovative FateControl technology expands the potential of Antibody Drug Conjugates (ADCs) to destroy cancer and avoid normal cells.
Cellares
4 followers
Tango Therapeutics
3 followers
Dyno Therapeutics
4 followers
Odyssey Therapeutics
2 followers
Gilead Sciences
161 followers
Regeneron
132 followers
Illumina
79 followers
Agilent Technologies
82 followers
Verily Life Sciences
45 followers
Alexion Pharmaceuticals
45 followers
GRAIL
29 followers
Explore companies